DFTX
Definium Therapeutics
DFTX
DFTX
208 hedge funds and large institutions have $909M invested in Definium Therapeutics in 2025 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 92 increasing their positions, 31 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
67% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 30
16.66% more ownership
Funds ownership: 52.23% → 68.89% (+17%)
7% more funds holding
Funds holding: 195 → 208 (+13)
Holders
208
Holding in Top 10
5
Calls
$23.4M
Puts
$10.8M
Top Buyers
| 1 | +$61.9M | |
| 2 | +$42.4M | |
| 3 | +$29.5M | |
| 4 |
BlackRock
New York
|
+$28.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.2M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$8.87M | |
| 3 | -$7.08M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$4.26M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.6M |
